| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052291 Chemically-modified progenipoietin conjugates |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | CA2576830A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632246A2 Medicament for local use |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1631243A2 Sexual hygienic composition |
| 03/08/2006 | EP1523483A4 Amino-bicyclic pyrazinones and pyridinones as coagulation serine protease inhibitors |
| 03/08/2006 | EP1451303A4 Detection of haematopoietic stem cells and progeny and uses thereof |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1385821A4 Novel anti-adhesive compounds and uses thereof |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1150704B1 Melagatran for the treatment of inflammation |
| 03/08/2006 | EP0910628B1 Inactivation resistant factor viii |
| 03/08/2006 | EP0804480B1 Purified thrombopoietin and method of making it |
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1744891A Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of EDHF function |
| 03/08/2006 | CN1744888A Medicine containing shikonin compound as active component |
| 03/08/2006 | CN1744884A Solid preparation for dialysis and process for producing the same |
| 03/08/2006 | CN1743326A Carboline carboxylate derivative, and its synthesizing method and use |
| 03/08/2006 | CN1743316A 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use |
| 03/08/2006 | CN1742943A Instant preparation of sealwort and preparation process thereof |
| 03/08/2006 | CN1742862A Guipi preparation and new preparing method therefor |
| 03/08/2006 | CN1742853A Compound medicine granulaes for treating entroendotoxinemia and preparing method |
| 03/08/2006 | CN1742814A Knotweed rhizome glycoside dropping pill, capsule, granules and tablet preparing method for treating cardiovascular and cerebrovascular diseases |
| 03/08/2006 | CN1742785A Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparing method |
| 03/08/2006 | CN1742743A Pseudo-ginseng saponin oral disintegration tablet and preparing method |
| 03/08/2006 | CN1742726A Piperazine ferulate oral cavity disintegrating tablet and preparing method |
| 03/08/2006 | CN1742725A Tirofiban hydrochloride freeze-dried powder injecta and preparing method |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244355C Series medicament of zanthoxylum bungeanum seed kernel oil and pseudo-ginseng total saponin and preparing process thereof |
| 03/08/2006 | CN1244338C Health care products for improving blood circulation and relieving fatigue of eye |
| 03/07/2006 | US7009039 obtained by mixing plasma proteins fibrinogen and Factor XIII with thrombin and at least one anti-fibrinolytic agent (tranexamic acid) in absence of organic chelating agent; implant for tissue engineering |
| 03/07/2006 | US7009036 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/02/2006 | WO2006023865A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | WO2006023397A2 Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
| 03/02/2006 | WO2006022356A1 Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 03/02/2006 | WO2006022091A1 Method of culturing human bone marrow-origin mesenchymal stem cells using human serum medium |
| 03/02/2006 | WO2005019429A3 Compositions and methods for enhancing phagocytosis or phagocyte activity |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060045853 Using tissue plasminogen activator finger domain specific immunolglobulins as tool in diagnosis of diabbetes and/or alzheimer's disease |
| 03/02/2006 | CA2577857A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | CA2577846A1 Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
| 03/02/2006 | CA2577676A1 Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1628978A2 Triaza-spiro compounds as nociceptin analogues and uses thereof |
| 03/01/2006 | EP1628972A1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/01/2006 | EP1628971A1 TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/01/2006 | EP1628968A1 4-imidazolin-2-one compounds |
| 03/01/2006 | EP1628954A2 Acylsulfamide inhibitors of factor viia |
| 03/01/2006 | EP1628668A2 1,1-disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibito rs |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP1503753A4 A method for inhibiting platelet aggregation |
| 03/01/2006 | EP1472255B1 Aza-arylpiperazines |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1263475B1 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 03/01/2006 | CN1742010A Novel chemical compounds |
| 03/01/2006 | CN1741996A Carboxamide derivatives and their use as factor XA inhibitors |
| 03/01/2006 | CN1739793A Human granulocyte-macrophage colony stimulating factor spray and its prepn process |
| 03/01/2006 | CN1739789A Somatostation a aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739728A Medicine composition for treating cardiac and cerebral vascular diseases and its prepn |
| 03/01/2006 | CN1739680A Chinese medicine for treating internal hemorrhage and its prepn process |
| 03/01/2006 | CN1739676A Chinese medicine mixture for treating leucopenia caused by tumor treating radiation therapy and chemotherapy and its quality control method |
| 03/01/2006 | CN1739609A Common lamiophlomis root prepn and its prepn process |
| 03/01/2006 | CN1739607A Common lamiophlomis root dripping pill and its prepn process |
| 03/01/2006 | CN1739593A New use of Herba siegesbeckiae extract |
| 03/01/2006 | CN1739590A Dispersion tablet containing notoginseng total saponin and its prepn |
| 03/01/2006 | CN1739531A Ferric saccharate injection for treating iron-deficiency anemia and its prepn process |
| 03/01/2006 | CN1739503A Compound medicine of ozagrel and its salt and troxerutin |
| 03/01/2006 | CN1739492A Electrostatic self-assembly process of preparing multiple medicine controlled releasing coating in exponential increase characteristic |
| 03/01/2006 | CN1243829C Gene of streptokinase, recombination protein and preparation method |
| 03/01/2006 | CN1243736C Process for preparation of 3-spiro'cyclohexam-1, 3'-'3H indolin-2'-one derivatives |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243541C 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage |
| 02/28/2006 | US7005553 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 02/28/2006 | US7005508 Nitroderivatives of polysaccharides |
| 02/28/2006 | US7005502 mixtures of von Willebrand factor(vWF) proteins and hemostatic agents, used for prophylaxis of blood disorders; antihemophilic factors |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | CA2347469C Esters of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 100,907 |
| 02/28/2006 | CA2204204C Carbohydrate derivatives |
| 02/23/2006 | WO2006018998A1 Method of constructing clone mammal |
| 02/23/2006 | WO2006018204A1 Modified vitamin k dependent polypeptides |